Form 4 for NEO NEOGENOMICS INC
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-11 · accession 0001077183-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-12 | 2022-01-11 | NEO | McKenzie Kathryn B | Chief Sustainability, Risk Ofcr | M - OptEx | $9.07 | +2,100 | 49.4K | +4% | +$19.0K |
| D | 2022-01-12 | 2022-01-11 | NEO | McKenzie Kathryn B | Chief Sustainability, Risk Ofcr | M - OptEx | $0.00 | -2,100 | 17.9K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-11 | M | A | 2,100 | $9.07 | 49,361 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-11 | M | D | 2,100 | $0.00 | 17,900 | D | $9.07 · — to 2022-10-18 | 2,100 Common Stock | (F1) On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. |